tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jeffrey Hung, 120 are a HOLD (35.71%), 18 are a SELL (5.36%), 198 are a BUY (58.93%).
Analyst Jeffrey Hung, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 62.93% that have a potential upside of 36.81% achieved within 212 days.
Jeffrey Hung’s has documented 673 price targets and ratings displayed on 47 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CTNM, Contineum Therapeutics, Common Stock.
Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for RYTM (RHYTHM PHARMACEUTICALS) at 11/9/2022. The price target of $26 was fulfilled within 2 days with a profit of $3.75 (16.85%) receiving and performance score of 84.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Dec-2025
$33
$12.32 (59.57%)
$37
Buy Since 16-Apr-2025
$34
$13.32 (64.41%)
$36
Buy Since 25-Nov-2019
$33
$12.32 (59.57%)
$36
Buy Since 24-Sep-2025
$31
$10.32 (49.90%)
$38
Buy Since 27-Feb-2024
$35
$14.32 (69.25%)
$41
Which stock is Jeffrey Hung most bullish on?
Which stock is Jeffrey Hung most reserved on?
What Year was the first public recommendation made by Jeffrey Hung?
